![]() |
市场调查报告书
商品编码
1423682
2030 年细胞培养皮革市场预测:按技术、应用和地区分類的全球分析Cell-Cultured Leather Market Forecasts to 2030 - Global Analysis By Technology (Collagen-based, Mycelium-based and Other Technologies), By Application (Apparel, Automotive, Footwear and Other Applications) and By Geography |
根据 Stratistics MRC 的数据,2023 年全球细胞培养皮革市场规模为 449 万美元,预计到 2030 年将达到 940 万美元,预测期内复合年增长率为 11.1%。
细胞培养皮革,也称为实验室种植或生物製造皮革,是采用细胞农业技术生产的。它模仿动物皮肤的发育过程,并涉及在受控的实验室环境中培养动物细胞。透过这个过程,胶原蛋白和其他蛋白质被生长并组装成具有与传统皮革相似的特性的材料,为传统动物皮革提供了永续的替代品。
对永续和无残忍产品的需求不断增长
消费者对永续性和道德实践的认识不断提高,推动了对细胞培养皮革的需求。随着消费者优先考虑环保选择,皮革产业因环境和动物福利问题而受到密切关注。细胞培养皮革透过提供无残忍且永续的替代品来满足这一需求。其无动物生产符合道德价值观,吸引了寻求负责任、生态意识时尚的消费者。人们对永续和无残忍产品的认识和偏好不断增强,正在推动市场成长。
扩大生产面临的挑战
由于生物製造的复杂性,扩大生产是细胞培养皮革市场的挑战。要实现大规模生产,同时保持产品品质和一致性,需要强大且具成本效益的生物加工技术。此外,建立高效的原材料供应链和获得大规模生产的监管批准已成为障碍,儘管需求不断增长,但仍影响了市场的快速扩充性。
素食和环保意识的消费者群体不断增长
随着道德和永续实践意识的不断增强,消费者正在寻找传统皮革的替代品。细胞培养皮革透过提供无残忍且环保的选择来符合这些价值观。对最大限度地减少环境影响和对动物伤害的产品的需求不断增长,使细胞培养皮革成为一个有吸引力的选择。利用这一趋势是市场成长和更广泛采用创新和永续材料的机会。
与替代合成皮革的竞争
来自合成皮革替代品的竞争对细胞培养皮革市场构成威胁。合成皮革生产成本低,製造製程成熟。聚氨酯和 PVC 人造皮革等合成材料的进步为消费者提供了更便宜、更广泛的选择,从而带来了挑战。此外,合成皮革产业的大规模生产能力和消费者对这些材料的熟悉程度阻碍了细胞培养皮革的快速普及。
COVID-19 大流行扰乱了细胞培养皮革市场的供应链和投资计划,造成了最初的挫折。然而,这场危机凸显了对永续和有弹性的供应链的需求,以及对环保替代品的兴趣增加。疫情期间,消费者对道德时尚和永续性的意识也大幅提升,推动了对零残忍产品的需求增加。消费行为的这些变化最终加速了市场的復苏和细胞培养皮革的采用。
箱包业务预计将在预测期内成为最大的业务
消费者对永续和无残忍时尚的日益偏好预计将引领箱包细分市场的发展。人们对细胞培养皮革的兴趣激增,特别是随着对环保替代品的需求增加,尤其是箱包等配件。此外,奢侈品牌与细胞培养皮革生产商之间的合作伙伴关係,旨在创造环保、高品质的产品,也进一步推动了这一领域的成长。
预计基于菌丝体的细分市场在预测期内复合年增长率最高。
由于其永续和多功能的性质,基于菌丝体的细分市场有望快速成长。菌丝体(真菌根结构)是製造细胞培养皮革的可再生资源。它能够模仿传统皮革的质地和特性,加上菌丝体培养技术的进步,支持了其巨大的潜力。此外,人们对环保替代品的兴趣日益浓厚,以及对研发的投资,使基于菌丝体的细胞培养皮革成为领跑者,预计该细分市场的复合年增长率最高。
由于对永续性的高度重视、严格的监管和强劲的技术创新,欧洲地区预计将占据最大的市场占有率。该地区优先考虑道德和环保实践,满足消费者对无捲曲和环保产品的需求。广泛的政府支持、研究投资以及学术界和工业界之间的合作正在推动技术进步。此外,奢侈时尚和汽车行业对替代材料的积极态度进一步巩固了欧洲在塑造细胞培养皮革市场方面的主导地位。
由于技术的快速进步和倾向于永续时尚的消费者基础的快速增长,预计亚太地区的市场将出现显着增长。随着纺织业的蓬勃发展和生态意识的转变,中国、日本和韩国等国家正大力投资创新技术。此外,支持永续实践的合作和政府措施的增加进一步增加了该地区细胞培养皮革的采用和生产大幅扩展的潜力。
According to Stratistics MRC, the Global Cell-Cultured Leather Market is accounted for $4.49 million in 2023 and is expected to reach $9.40 million by 2030 growing at a CAGR of 11.1% during the forecast period. Cell-cultured leather, also known as lab-grown or biofabricated leather is produced using cellular agriculture techniques. It involves cultivating animal cells in a controlled lab environment, mimicking the process of animal skin development. Through this process, collagen and other proteins are grown and assembled into material with characteristics similar to traditional leather, offering a sustainable and cruelty-free alternative to conventional animal-derived leather.
Rising demand for sustainable and cruelty-free products
The growing consumer consciousness towards sustainability and ethical practices propels the demand for cell-cultured leather. As consumers prioritise eco-friendly choices, the leather industry faces scrutiny due to environmental concerns and animal welfare. Cell-cultured leather, offering a cruelty-free and sustainable alternative, meets this demand. Its production without animal involvement aligns with ethical values, attracting consumers seeking responsible, eco-conscious fashion. This heightened awareness and preference for sustainable, cruelty-free products drives the market's growth.
Challenges in scaling up production
Scaling up production poses challenges in the cell-cultured leather market due to the complex nature of biomanufacturing. Achieving large-scale production while maintaining product quality and consistency demands robust and cost-effective bioprocessing techniques. Additionally, establishing efficient supply chains for raw materials and securing regulatory approvals for mass production present hurdles, impacting the market's swift scalability despite growing demand.
Growth of the vegan and eco-conscious consumer base
Owing to rising awareness of ethical and sustainable practices, consumers seek alternatives to traditional leather. Cell-cultured leather, offering a cruelty-free and eco-friendly option, aligns with these values. The growing demand for products that minimise environmental impact and animal harm positions cell-cultured leather as an attractive choice. Capitalising on this trend presents an opportune moment for market growth and wider adoption of innovative, sustainable materials.
Competition from synthetic leather alternatives
Competition from synthetic leather alternatives poses a threat to the cell-cultured leather market. Synthetic leather offers lower production costs and established manufacturing processes. Advances in synthetic materials, such as polyurethane and PVC-based faux leather, pose a challenge by providing a cheaper and more widely available option for consumers. Additionally, the synthetic leather industry's capacity for large-scale production and the familiarity of consumers with these materials hinder the rapid adoption of cell-cultured leather.
The COVID-19 pandemic disrupted supply chains and investment plans in the cell-cultured leather market, causing initial setbacks. However, the crisis underscored the need for sustainable and resilient supply chains, fueling increased interest in eco-friendly alternatives. Consumer awareness regarding ethical fashion and sustainability also surged during the pandemic, driving a heightened demand for cruelty-free products. This shift in consumer behaviour ultimately accelerated the market's recovery and adoption of cell-cultured leather.
The luggage & bags segment is expected to be the largest during the forecast period
The luggage and bags segment is anticipated to lead the market due to increasing consumer preferences for sustainable and cruelty-free fashion. As the demand for eco-friendly alternatives grows particularly in accessories like bags and luggage, there's a surge in interest in cell-cultured leather. Additionally, partnerships between luxury brands and cell-cultured leather producers to create high-quality environmentally conscious products further drive the segment's growth.
The mycelium-based segment is expected to have the highest CAGR during the forecast period
The mycelium-based segment is poised for rapid growth due to its sustainable and versatile nature. Mycelium, the root structure of fungi, serves as a renewable resource for creating cell-cultured leather. Its ability to mimic the texture and properties of traditional leather, coupled with advancements in mycelium cultivation techniques, drives its high potential. In addition, growing interest in eco-friendly alternatives, coupled with investments in research and development, positions mycelium-based cell-cultured leather as a frontrunner, projecting the segment's highest CAGR.
The European region is estimated to witness the largest market share owing to its strong focus on sustainability, stringent regulations and robust innovation. The region prioritises ethical and environmentally friendly practices, aligning with consumer demands for cruelty-free and eco-conscious products. Extensive government support, research investments and collaborations between academia and industry fuel technological advancements. Moreover, a proactive approach towards alternative materials in the luxury fashion and automotive industries further cements Europe's dominance in shaping the cell-cultured leather market.
The Asia Pacific region is primed for substantial growth in the market due to burgeoning technological advancements and a burgeoning consumer base inclined towards sustainable fashion. With a thriving textile industry and a shift towards eco-consciousness, countries like China, Japan and South Korea are investing heavily in innovative technologies. Additionally, increasing collaborations and government initiatives supporting sustainable practices further bolster the region's potential for significant expansion in cell-cultured leather adoption and production.
Key players in the market
Some of the key players in Cell-Cultured Leather Market include Biofabricate, Biomason, Bioworks, Bolt Threads, CELLINK, Geltor, Modern Meadow, Mycotech, MycoWorks, Orbillion Bio, TerViva, TextileGenesis, Tiamat Sciences, Triton Algae Innovations and VitroLabs.
In July 2023, Modern Meadow raised Series D funding. The funding is led by Astanor Ventures, Horizons Ventures, and Key Partners Capital, which will support Modern Meadow to continue its innovation.
In May 2022, VitroLabs Inc raised US$ 46 million to build and scale the world's first pilot production of cell-cultivated leather. The Series A funding is led by Agronomics; other investors include BESTSELLER's Invest FWD, global luxury group Kering, Khosla Ventures, actor and environmentalist Leonardo DiCaprio, New Agrarian, and Regeneration.VC. Moreover, Kering continues its partnership with VitroLabs Inc in bringing support for product quality testing, tanning, and finishing.